Combined oncolytic adenovirus DNX-2401 and anti-PD-checkpoint inhibitor pembrolizumab for recurrent glioblastoma. Combined oncolytic adenovirus DNX-2401 and anti-PD-checkpoint inhibitor pembrolizumab for recurrent glioblastoma
收藏NIAID Data Ecosystem2026-03-14 收录
官方服务：
资源简介：
Gene expression data for samples included in this trial of DNX2401 and pembrolizumab for recurrent glioma Overall design: Observational cohort CAPTIVE investigators
创建时间：
2023-03-08
